White Paper

21 CFR Part 11 — Are You Ready For An FDA Inspection?

By James Jardine

FDA-letters

When the U.S. Food and Drug Administration (FDA) issued 21 CFR Part 11 in 1997,1 the internet existed but it was not as ubiquitous as it is today. Google wasn’t around yet. Life science companies submitted documents to the FDA by the truckload because paper records were the norm.

In many ways, Part 11 was an acknowledgement of the inevitable movement toward the use of electronic systems in compliance. The regulation established the criteria for the use of electronic records and electronic signatures by organizations that comply with the Food, Drug, and Cosmetic Act and the Public Health Service Act. It applies to all FDA-regulated companies.

Part 11 has been scrutinized and criticized over the years, but it remains in effect today. Given the pervasive automation of processes and digitization of data today, the regulation is more relevant than ever. In this paper we break down what Part 11 means and how to get inspection ready.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of ECM Connection? Subscribe today.

Subscribe to ECM Connection X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to ECM Connection